The FDA recently announced that new patient guides including serious warnings about possible side effects will be required for allADHD medications. These side affects include heart problems, stroke, and psychiatric problems. In some cases the medications even contribute to sudden death.

While the FDA has required warnings on the labels of these medications, the new patient guides are designed to provide the consumer with more information about possible problems associated with the ADHD medications. The requirement comes in the wake of criticism that the FDA hasn’t brought enough attention to the heart and psychiatric problems caused by many ADHD medications.

It is estimated that 4 million American children and adults take some form of ADHD medication. These guides, which are pamphlets given to patients when the drug is prescribed, will inform those taking the drugs about possible risks as well as preventative measures they should take before and during their treatment with the drugs.

Patients taking ADHD medications such as Adderall, Strattera,Ritalin, Dexedrine, and Concerta have experienced cardiovascular problems including heart attack and stroke. Psychiatric problems encountered while taking the drugs include hallucinations, hearing voices, paranoia, and mania. Patients should be given a thorough physical and psychiatric exam before taking the medication, and regular check-ups with the doctor should be performed to check for any possible cardiovascular or psychiatric problems.

The FDA does not want to discourage anyone from taking ADHD medication. Instead, it is hoped that these guides will encourage patients and doctors to be aware of risks and take measures to ensure the medications’ safe usage.

Comments are closed.